바이오메디컬 텍스타일 시장(2024-2031년)

Biomedical Textiles Market Size, Share & Trends Analysis Report by Fiber Type (Non-Biodegradable and Biodegradable), by Fabric Type (Non-Woven and Woven), and by Application (Non-Implantable and Surgical Sutures) Forecast Period (2023-2030)

Biomedical textiles market is anticipated to grow at a CAGR of 6.2% during the forecast period (2023-2030). The market's growth is attributed to technological advancements across the globe. Textile technological improvements have enabled the production of textiles with improved antibacterial and cleaning capabilities, driving market growth. According to the MDPI, in September 2023, microplastics from textiles such as polyester (PET) pose a significant concern. Studies indicate that up to 72,000 microplastic fibers per gram of textile can be released during washing, with median fiber lengths ranging from 165 to 841 μm. Over 20,000 fibers per day are carried downstream by river and up to 213,200 fibers per square kilometer have been detected on the ocean's surface. Plastic littering is a global crisis, which is prompting a transition towards materials that degrade in nature.

Furthermore, Bio-based and biodegradable polymers are becoming increasingly popular in the textile industry. The clothing sector is expected to be the main contributor to the growth of this market in the next decade. Biodegradable plastics are the ideal choice when the product or litter is unintentionally disposed of in nature, where aerobic or anaerobic digestion and composting are the most suitable methods of disposal.

Segmental Outlook

The global biomedical textiles market is segmented on the fiber type, fabric type, and application. Based on the fiber type, the market is sub-segmented into non-biodegradable, and biodegradable. Based on the fabric type, the market is sub-segmented into non-woven, and woven. Furthermore, on the basis of application, the market is sub-segmented into non-implantable, and surgical sutures. The non-biodegradable subcategory is expected to capture a significant portion of the market share within the fiber type segment. This is attributed to the increased consumption in non-implantable applications. The growing awareness of the benefits of utilizing this fiber in the healthcare sector is projected to propel market growth.

The Non-Woven Sub-Segment is Anticipated to Hold a Considerable Share of the Global Biomedical Textiles Market

Among the fabric type, the non-woven sub-segment is expected to hold a considerable share of the global biomedical textiles market. Non-woven fabrics provide essential safety qualities such as infection prevention and disease avoidance by preventing cross-contamination and infection transmission in a medical or surgical environment. Furthermore, nonwovens have been used more and more in the creation of smart wound care devices, with features such as promoting moist wound healing conditions, minimizing skin adhesion, and controlling vapor transmission. Non-woven fabrics are commonly used in surgical dressings, bandages, and implant applications, and non-woven fabrics are utilized in a variety of biomedical textiles, including sheets, tubes, gowns, face masks, scrub suits, shoe covers, head covers, sponges, wipes, and plugs, among others. Nonwoven materials are additionally more versatile, cost-effective, disposable, and efficient than woven fabrics, leading to growing use of healthcare applications.

Regional Outlook

The global biomedical textiles market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the rise in chronic wounds and surgical operations. Furthermore, increased healthcare financing and rapid growth of the healthcare business in developing nations such as India and China are boosting market revenue growth.

Global Biomedical Textiles Market Growth by Region 2023-2030

Source: OMR Analysis

The North America Region is Expected to Grow at a Significant CAGR in the Global Biomedical Textiles Market

Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising diverse medical applications. Polyester-based materials are increasingly being used, as they are compatible with a wide range of medical applications. They can be utilized to produce tissue engineering scaffolds, wound dressings that encourage healing, biocompatible surgical implants, and treatments such as vascular reconstructive surgery and ophthalmology. According to National Institute of Health (NIH), in February 2022, Polyester-based materials are used in a variety of medical applications, including hard and soft tissue engineering, wound dressings, surgical implants, vascular reconstructive surgery, ophthalmology, and prevention of multi-resistant infection. The usage of polyester materials in the medical field has increased by at least 20.0% since the start of the COVID-19 pandemic, with 25.0%-50.0% of all medical applications using polyester materials and the remaining percentage being provided by other types of natural or synthetic polymers, such as 25.0% polyolefins in personal protection equipment (PPE).

Market Players Outlook

The major companies serving the global biomedical textiles market include Cardinal Health, DSM, Essity AB, HARTMANN USA, Inc., and Integra LifeSciences Corp., among others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in August 2019, Paul Hartmann AG acquired Safran Coating, the acquisition is designed to assist the expansion of new wound care solutions and improve patient quality of life.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global biomedical textiles market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies. Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1.Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1.Research Methods and Tools
• 1.2.Market Breakdown
  • 1.2.1.By Segments
  • 1.2.2.By Region

2.Market Overview and Insights

• 2.1.Scope of the Report
• 2.2.Analyst Insight & Current Market Trends
  • 2.2.1.Key Findings
  • 2.2.2.Recommendations
  • 2.2.3.Conclusion

3.Competitive Landscape

• 3.1.Key Company Analysis
• 3.2.B. Braun SE
  • 3.2.1.Overview
  • 3.2.2.Financial Analysis
  • 3.2.3.SWOT Analysis
  • 3.2.4.Recent Developments
• 3.3.Bally Ribbon Mills
  • 3.3.1.Overview
  • 3.3.2.Financial Analysis
  • 3.3.3.SWOT Analysis
  • 3.3.4.Recent Developments
• 3.4.Biotechnology Center
  • 3.4.1.Overview
  • 3.4.2.Financial Analysis
  • 3.4.3.SWOT Analysis
  • 3.4.4.Recent Developments
• 3.5.Key Strategy Analysis

4.Market Segmentation

• 4.1.Global Biomedical Textiles Market by Fiber Type
  • 4.1.1.Non-Biodegradable
  • 4.1.2.Biodegradable
• 4.2.Global Biomedical Textiles Market by Fabric Type
  • 4.2.1.Non-Woven
  • 4.2.2.Woven
• 4.3.Global Biomedical Textiles Market by Application
  • 4.3.1.Non-Implantable
  • 4.3.2.Surgical Sutures

5.Regional Analysis

• 5.1.North America
  • 5.1.1.United States
  • 5.1.2.Canada
• 5.2.Europe
  • 5.2.1.UK
  • 5.2.2.Germany
  • 5.2.3.Italy
  • 5.2.4.Spain
  • 5.2.5.France
  • 5.2.6.Rest of Europe
• 5.3.Asia-Pacific
  • 5.3.1.China
  • 5.3.2.India
  • 5.3.3.Japan
  • 5.3.4.South Korea
  • 5.3.5.Rest of Asia-Pacific
• 5.4.Rest of the World

6.Company Profiles

• 6.1.Cardinal Health
• 6.2.DSM
• 6.3.Essity AB
• 6.4.HARTMANN USA, Inc.
• 6.5.Integra LifeSciences Corp.
• 6.6.Johnson & Johnson Pvt. Ltd.
• 6.7.Medline International B.V.
• 6.8.MEISTER MASCHINEN Handels + Service GmbH
• 6.9.Poly-med
• 6.10.Secant Group, LLC
• 6.11.Swicofil AG
• 6.12.Paul Hartmann AG